Stock Analysis
- Singapore
- /
- Real Estate
- /
- SGX:T24
Tuan Sing Holdings Full Year 2023 Earnings: EPS: S$0.004 (vs S$0.004 in FY 2022)
Tuan Sing Holdings (SGX:T24) Full Year 2023 Results
Key Financial Results
- Revenue: S$303.7m (up 35% from FY 2022).
- Net income: S$4.84m (up 5.3% from FY 2022).
- Profit margin: 1.6% (down from 2.0% in FY 2022).
- EPS: S$0.004 (in line with FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Tuan Sing Holdings' share price is broadly unchanged from a week ago.
Risk Analysis
It is worth noting though that we have found 4 warning signs for Tuan Sing Holdings (2 shouldn't be ignored!) that you need to take into consideration.
Valuation is complex, but we're helping make it simple.
Find out whether Tuan Sing Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Simply Wall St
About SGX:T24
Tuan Sing Holdings
Tuan Sing Holdings Limited, an investment holding company, engages in the property development and investment, hotels investment, and industrial services businesses in Singapore, Australia, China, Malaysia, and Indonesia.
Average dividend payer with questionable track record.